Sign in

CIK 0001651308 · Large accelerated filer

BeOne Medicines Ltd.

Sign in to watch
Ticker
BEIGF
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
981209416
Phone
41-616851900
Business address
C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
Former names
BeiGene, Ltd.

Securities

  • ONC American Depositary Shares Nasdaq
  • BEIGF Common stock OTC
  1. 144 Insider Sale of Securities
  2. 4 Planned sale Chief Executive Officer sold 27,802 shares at an average $253.38 ($7,044,591)
  3. 144 Insider Sale of Securities
  4. 144 Insider Sale of Securities
  5. 4 Open-market sale Global Head of R&D sold 1,028 shares at $260.00 ($267,280)
  6. 4 Open-market sale President and COO sold 1,363 shares at $260.00 ($354,380)
  7. 4 Planned sale Director sold 2,007 shares at an average $265.50 ($532,867)
  8. 4 Open-market sale Chief Executive Officer sold 3,174 shares at an average $261.61 ($830,360)
  9. 144 Insider Sale of Securities
  10. 144 Insider Sale of Securities
  11. 144 Insider Sale of Securities
  12. 144 Insider Sale of Securities
  13. 4 Open-market sale SVP, General Counsel sold 422 shares at $266.50 ($112,463)
  14. 4 Open-market sale Global Head of R&D sold 1,647 shares at an average $262.11 ($431,699)
  15. 4 Open-market sale President and COO sold 2,173 shares at an average $261.27 ($567,742)
  16. 4 Open-market sale Chief Executive Officer sold 5,140 shares at an average $263.33 ($1,353,520)
  17. UPLOAD Other SEC-generated Letter
  18. 144 Insider Sale of Securities
  19. 144 Insider Sale of Securities
  20. 144 Insider Sale of Securities

Page 10 of 64 · 1,278 filings